95 related articles for article (PubMed ID: 21118151)
21. The Chk2 protein kinase.
Ahn J; Urist M; Prives C
DNA Repair (Amst); 2004; 3(8-9):1039-47. PubMed ID: 15279791
[TBL] [Abstract][Full Text] [Related]
22. Cell cycle-dependent DNA damage signaling induced by ICRF-193 involves ATM, ATR, CHK2, and BRCA1.
Park I; Avraham HK
Exp Cell Res; 2006 Jul; 312(11):1996-2008. PubMed ID: 16630610
[TBL] [Abstract][Full Text] [Related]
23. Inducible degradation of checkpoint kinase 2 links to cisplatin-induced resistance in ovarian cancer cells.
Zhang P; Gao W; Li H; Reed E; Chen F
Biochem Biophys Res Commun; 2005 Mar; 328(2):567-72. PubMed ID: 15694385
[TBL] [Abstract][Full Text] [Related]
24. Truncating APC mutations have dominant effects on proliferation, spindle checkpoint control, survival and chromosome stability.
Tighe A; Johnson VL; Taylor SS
J Cell Sci; 2004 Dec; 117(Pt 26):6339-53. PubMed ID: 15561772
[TBL] [Abstract][Full Text] [Related]
25. CHK2 overexpression and mislocalisation within mitotic structures enhances chromosomal instability and hepatocellular carcinoma progression.
Carloni V; Lulli M; Madiai S; Mello T; Hall A; Luong TV; Pinzani M; Rombouts K; Galli A
Gut; 2018 Feb; 67(2):348-361. PubMed ID: 28360097
[TBL] [Abstract][Full Text] [Related]
26. DNA-PKcs activates the Chk2-Brca1 pathway during mitosis to ensure chromosomal stability.
Shang Z; Yu L; Lin YF; Matsunaga S; Shen CY; Chen BP
Oncogenesis; 2014 Feb; 3(2):e85. PubMed ID: 24492479
[TBL] [Abstract][Full Text] [Related]
27. Role for ATM in DNA damage-induced phosphorylation of BRCA1.
Gatei M; Scott SP; Filippovitch I; Soronika N; Lavin MF; Weber B; Khanna KK
Cancer Res; 2000 Jun; 60(12):3299-304. PubMed ID: 10866324
[TBL] [Abstract][Full Text] [Related]
28. Uterus hyperplasia and increased carcinogen-induced tumorigenesis in mice carrying a targeted mutation of the Chk2 phosphorylation site in Brca1.
Kim SS; Cao L; Li C; Xu X; Huber LJ; Chodosh LA; Deng CX
Mol Cell Biol; 2004 Nov; 24(21):9498-507. PubMed ID: 15485917
[TBL] [Abstract][Full Text] [Related]
29. p53 activation in response to mitotic spindle damage requires signaling via BubR1-mediated phosphorylation.
Ha GH; Baek KH; Kim HS; Jeong SJ; Kim CM; McKeon F; Lee CW
Cancer Res; 2007 Aug; 67(15):7155-64. PubMed ID: 17671183
[TBL] [Abstract][Full Text] [Related]
30. Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage.
Bahassi el M; Myer DL; McKenney RJ; Hennigan RF; Stambrook PJ
Mutat Res; 2006 Apr; 596(1-2):166-76. PubMed ID: 16481012
[TBL] [Abstract][Full Text] [Related]
31. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores.
Ditchfield C; Johnson VL; Tighe A; Ellston R; Haworth C; Johnson T; Mortlock A; Keen N; Taylor SS
J Cell Biol; 2003 Apr; 161(2):267-80. PubMed ID: 12719470
[TBL] [Abstract][Full Text] [Related]
32. Subcellular localization of the BRCA1 gene product in mitotic cells.
Lotti LV; Ottini L; D'Amico C; Gradini R; Cama A; Belleudi F; Frati L; Torrisi MR; Mariani-Costantini R
Genes Chromosomes Cancer; 2002 Nov; 35(3):193-203. PubMed ID: 12353262
[TBL] [Abstract][Full Text] [Related]
33. Loss of BRCA1 impairs centromeric cohesion and triggers chromosomal instability.
Di Paolo A; Racca C; Calsou P; Larminat F
FASEB J; 2014 Dec; 28(12):5250-61. PubMed ID: 25205741
[TBL] [Abstract][Full Text] [Related]
34. Aberrations of the Chk2 tumour suppressor in advanced urinary bladder cancer.
Bartkova J; Guldberg P; Grønbaek K; Koed K; Primdahl H; Møller K; Lukas J; Ørntoft TF; Bartek J
Oncogene; 2004 Nov; 23(52):8545-51. PubMed ID: 15361851
[TBL] [Abstract][Full Text] [Related]
35. Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells.
Ertych N; Stolz A; Stenzinger A; Weichert W; Kaulfuß S; Burfeind P; Aigner A; Wordeman L; Bastians H
Nat Cell Biol; 2014 Aug; 16(8):779-91. PubMed ID: 24976383
[TBL] [Abstract][Full Text] [Related]
36. BRCA1 downregulation leads to premature inactivation of spindle checkpoint and confers paclitaxel resistance.
Chabalier C; Lamare C; Racca C; Privat M; Valette A; Larminat F
Cell Cycle; 2006 May; 5(9):1001-7. PubMed ID: 16639080
[TBL] [Abstract][Full Text] [Related]
37. On the road to cancer: aneuploidy and the mitotic checkpoint.
Kops GJ; Weaver BA; Cleveland DW
Nat Rev Cancer; 2005 Oct; 5(10):773-85. PubMed ID: 16195750
[TBL] [Abstract][Full Text] [Related]
38. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells.
Xu X; Weaver Z; Linke SP; Li C; Gotay J; Wang XW; Harris CC; Ried T; Deng CX
Mol Cell; 1999 Mar; 3(3):389-95. PubMed ID: 10198641
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of cytokinesis failure in ovarian cystadenomas with defective BRCA1 and P53 pathways.
Austria T; Marion C; Yu V; Widschwendter M; Hinton DR; Dubeau L
Int J Cancer; 2018 Dec; 143(11):2932-2942. PubMed ID: 29978915
[TBL] [Abstract][Full Text] [Related]
40. BRCA1 interaction of centrosomal protein Nlp is required for successful mitotic progression.
Jin S; Gao H; Mazzacurati L; Wang Y; Fan W; Chen Q; Yu W; Wang M; Zhu X; Zhang C; Zhan Q
J Biol Chem; 2009 Aug; 284(34):22970-7. PubMed ID: 19509300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
